Endometrial Cancer Trial, Recruiting (NCT07214584)

Endometrial Cancer Trial, Recruiting NCT07214584 Sponsor: University of Florida Condition: Endometrial Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07214584 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Endometrial Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 years or older
People who have been diagnosed with a cervical cancer caused by HPV (Human Papillomavirus), specifically one of three types: squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma
People whose cancer has been diagnosed at Stage I or higher, including those whose cancer has spread to other parts of the body
People who have had standard imaging scans (such as CT or MRI) before treatment, with plans to have further imaging scans during and after treatment
People who are willing to have research-related blood tests and cervical mucus samples taken as part of the study

Who may not be able to join:

People who are unable to give informed consent, or who do not wish to sign a consent form
People who do not meet the inclusion criteria listed above
People who are unable to attend follow-up appointments as required by the trial schedule
People who have been diagnosed with a second, separate cancer at the same time that also requires active cancer treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 9 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 352-265-8827

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07214584

Sponsor: University of Florida

Phase: Not Applicable

Status: Recruiting

Condition: Endometrial Cancer

Trial contact: 352-265-8827

More information: https://clinicaltrials.gov/study/NCT07214584

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 years or older
People who have been diagnosed with a cervical cancer caused by HPV (Human Papillomavirus), specifically one of three types: squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma
People whose cancer has been diagnosed at Stage I or higher, including those whose cancer has spread to other parts of the body
People who have had standard imaging scans (such as CT or MRI) before treatment, with plans to have further imaging scans during and after treatment
People who are willing to have research-related blood tests and cervical mucus samples taken as part of the study

Who may not be able to join:

People who are unable to give informed consent, or who do not wish to sign a consent form
People who do not meet the inclusion criteria listed above
People who are unable to attend follow-up appointments as required by the trial schedule
People who have been diagnosed with a second, separate cancer at the same time that also requires active cancer treatment

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 9 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Florida

Registry

ClinicalTrials.gov

Start date

15 December 2025

Est. completion

30 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of Circulating HPV DNA/mRNA Liquid Biopsy for Evaluating Treatment Response in Cervical Cancer

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov